Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Excessive hair growth in women can be treated with medications like spironolactone and finasteride, and male-pattern baldness in women can be improved with similar treatments.

The document reports the first Brazilian case of a girl with Becker nevus syndrome, characterized by skin changes, breast underdevelopment, and scoliosis.

All treatments reduce hair growth; low dose flutamide most effective with fewer side effects.

Testosterone can cause acne and male-pattern baldness, affects hair growth in men and women, and makes male skin more sensitive.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

More pediatric-specific research and guidelines are needed to improve hidradenitis suppurativa treatment in children and adolescents.

Certain medications and maintaining adequate iron levels can help manage women's hair loss.

Treat pattern hair loss with finasteride and topical minoxidil.

Umbilical cord-derived media is safe and effective for hair growth.

AGA is a common hair loss affecting both genders, treated with various therapies to promote regrowth and slow thinning.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

Certain medications including flutamide, spironolactone, and others effectively reduce excessive hair growth in women, especially when combined with lifestyle changes.

Hair loss affects women's self-esteem; treatments like minoxidil can help.

Liposomal systems show promise for delivering drugs through the skin but face challenges like high costs and stability issues.

Simvastatin may help manage symptoms in women with non-classic congenital adrenal hyperplasia by lowering cholesterol and certain hormone levels.

Dutasteride-containing mesotherapy effectively treats female hair loss, improving density and thickness with minimal side effects.

Women with myotonic dystrophy might get diseases related to male hormones because their body tissues are extra sensitive to these hormones.

Iron deficiency is common in women regardless of hair loss, and treating it does not usually reverse hair loss.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

Ludwig pattern hair loss in women results from varying sensitivity in hair follicles, causing fewer visible hairs.

The hair shedding scale accurately identifies abnormal hair shedding in women with long hair, with grades 5 and 6 indicating excessive shedding.

The document concluded that cyproterone acetate and minoxidil are effective for female hair loss, and a supportive doctor-patient relationship is important.

Both genetic and lifestyle factors significantly affect female hair loss.

People with early-onset androgenetic alopecia may have a higher risk of heart disease due to abnormal blood lipid levels.

Stem cell therapies could be a promising alternative for hair loss treatment, but more research is needed to understand their full potential and safety.

The document suggests new ways to assess and diagnose hyperandrogenism to improve accuracy.

The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.